RnRMarketReserach.com adds Lateral Epicondylitis (Tennis Elbow) – Pipeline Review, H2 2014 to its store. The analysis provides an overview of the Lateral Epicondylitis (Tennis Elbow)’s therapeutic pipeline.

Dallas, TX -- (SBWire) -- 11/24/2014 --The report “Lateral Epicondylitis (Tennis Elbow) – Pipeline Review, H2 2014” provides comprehensive information on the therapeutic development for Lateral Epicondylitis (Tennis Elbow), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lateral Epicondylitis (Tennis Elbow) and special features on late-stage and discontinued projects.

Complete Report is Available
http://www.rnrmarketresearch.com/lateral-epicondylitis-tennis-elbow-pipeline-review-h2-2014-market-report.html

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Tennis elbow is a condition in which the outer part of the elbow becomes painful and warm. Companies discussed in this Lateral Epicondylitis (Tennis Elbow) – Pipeline Review, H2 2014 report include Kasiak Research Pvt. Ltd., Molecular Pharmacology (USA) Limited, RepliCel Life Sciences, Inc., Seikagaku Corporation, Teikoku Pharma USA, Inc.

Order a Purchase copy of this report
http://www.rnrmarketresearch.com/contacts/purchase?rname=242183

Drugs profile discussed in this Lateral Epicondylitis (Tennis Elbow) – Pipeline Review, H2 2014 report include ALLO-ASC, hyaluronate sodium, MPLTL-100, RCT-01, Refaheal, TPW-182.

Scope of this report as follows The report provides a snapshot of the global therapeutic landscape of Lateral Epicondylitis (Tennis Elbow). The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Lateral Epicondylitis (Tennis Elbow) and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects. A review of the Lateral Epicondylitis (Tennis Elbow) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects. Coverage of the Lateral Epicondylitis (Tennis Elbow) pipeline on the basis of target, MoA, route of administration and molecule type. Latest news and deals relating related to pipeline products.

Inquire before buying
http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=242183

(This is a premium report priced at US$2000 for a single user License.)

Reasons to buy this report “Lateral Epicondylitis (Tennis Elbow) – Pipeline Review, H2 2014” as follows Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Develop strategic initiatives by understanding the focus areas of leading companies. Identify and understand important and diverse types of therapeutics under development for Lateral Epicondylitis (Tennis Elbow). Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline. Devise corrective measures for pipeline projects by understanding Lateral Epicondylitis (Tennis Elbow) pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Explore more reports on Orthopedic therapeutics industry
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/orthopedic-therapeutics

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.